Table 2.
Characteristics of a Public data set of COVID-19 and a Cases series of SARS, in 2003.
| COVID-19 | SARS | |||
|---|---|---|---|---|
| Deceased (n = 37) | Survived (n = 1019) | Deceased (n = 139) | Survived (n = 385) | |
| Age, median (range) – year | 70 (65–81)** | 47 (35–57) | 57 (45–69)†† | 32 (24–44) |
| Male – n (%) | 26 (70.3)* | 510 (50.0) | 74 (53.2)† | 163 (42.3) |
| Symptoms | ||||
| Fever – n (%) | 32 (86.5) | 136 (97.8) | 379 (98.4) | |
| Diarrhea – n (%) | 7 (18.9) | 30 (21.6) | 26 (6.8) | |
| Cough – n (%) | 25 (67.6) | 107 (77.0) | 185 (48.1) | |
| Comorbidities – n (%) | 24 (64.9) | 79 (56.8)†† | 69 (17.9) | |
| Hypertension – n (%) | 18 (48.6) | 64 (46.0)†† | 44 (11.4) | |
| Diabetes history – n (%) | 11(29.7) | 30 (21.6)†† | 15 (3.9) | |
| Cardiovascular disease – n (%) | 8 (21.6) | 40 (28.8)†† | 23 (6.0) | |
| Chronic lung disease – n (%) | 3 (8.1) | 5 (3.6) | 6 (1. 6) | |
| From onset to death, median (range) – day | 13 (11–18) | 15 (10–19) | ||
Data are presented as medians (interquartile ranges, IQR) and n (%).
*
p < 0.05,
**
p < 0.01, vs. COVID-19 survived patients.
†
p < 0.05,
††
p < 0.01, vs. SARS survived patients.